- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02948192
The Reproductive Microbiome & Perinatal Health Outcomes
January 13, 2020 updated by: Baylor Research Institute
The Reproductive Microbiome & Perinatal Health Outcome
Pregnant African American women between 18 and 45 years of age will be enrolled at 20 weeks of gestation or less.
Biological specimens (vaginal swabs, rectal swab) will be collected at enrollment, 23-24 weeks, at 28-29 weeks, and at the onset of labor.
A urine sample will be obtained at entry and at the time of delivery for metabolomic analysis.
Participants will also collect a dietary survey at entry, 23-24 weeks, and 28-29 weeks.
The biological specimens will then be analyzed for their microbiomial profile.
This will then be correlated with the timing of their delivery as well as other comorbidities such as obesity, hypertension, and diabetes.
Study Overview
Status
Terminated
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
55
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 45 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
African american women between 18 and 45 years of age who are pregnant with a singleton and present for prenatal care at 20 weeks of gestation or less.
Description
Inclusion Criteria:
- Able to read and understand English, full decision making capabilities, African American (self-identified), Pregnant, At 20 weeks or less of gestation, Singleton pregnancy, 18-45 years of age
Exclusion Criteria:
- Race other than African American, Advanced gestational age (>20 weeks), Multiple gestations, Less than 18 years or greater than 45 years of age.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Preterm Delivery
African american women who present for prenatal care who experience spontaneous preterm birth
|
Survey is collected on the dietary intake of both cohorts.
Sample collection is done from patients in both cohorts at multiple time points.
|
|
Term delivery
African american women who present for prenatal care who experience term birth
|
Survey is collected on the dietary intake of both cohorts.
Sample collection is done from patients in both cohorts at multiple time points.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Preterm Delivery
Time Frame: 36 weeks
|
Onset of preterm labor with subsequent spontaneous preterm birth
|
36 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Microbiome profile
Time Frame: 36 weeks
|
Evaluation of characteristics of the vaginal microbiome in cohorts
|
36 weeks
|
|
Metabolomic profile
Time Frame: 36 weeks
|
Evaluation of characteristics of the metabolomic products present in cohort
|
36 weeks
|
|
Medical comorbidities
Time Frame: 36 weeks
|
Evaluation of the comorbidities present in the cohort
|
36 weeks
|
|
Gut Microbiome profile
Time Frame: 36 weeks
|
Evaluation of the characteristics of the gastrointestinal microbiome in cohorts
|
36 weeks
|
|
Term delivery
Time Frame: 36 weeks
|
Delivery at term
|
36 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 1, 2016
Primary Completion (Actual)
November 1, 2019
Study Completion (Actual)
November 1, 2019
Study Registration Dates
First Submitted
October 26, 2016
First Submitted That Met QC Criteria
October 26, 2016
First Posted (Estimate)
October 28, 2016
Study Record Updates
Last Update Posted (Actual)
January 18, 2020
Last Update Submitted That Met QC Criteria
January 13, 2020
Last Verified
January 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 016-194
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on PreTerm Birth
-
University of WashingtonRecruitingVery Preterm and Extremely Preterm BirthUnited States
-
Federico II UniversityRecruiting
-
University of OxfordShoklo Malaria Research UnitCompleted
-
Chelsea and Westminster NHS Foundation TrustSPD Development Company Limited; Borne CharityRecruitingPreterm Birth | Preterm Labor | Preterm Birth Complication | Preterm Premature Rupture of Membrane | Preterm PregnancyUnited Kingdom
-
Cairo UniversityCompleted
-
University of OklahomaCompletedPreTerm Birth | PreTerm NeonateUnited States
-
Eunice Kennedy Shriver National Institute of Child...CompletedPregnancy | Preterm Birth | Preterm LaborUnited States
-
University Hospital Inselspital, BerneAmniSure International LLCCompletedPreterm Birth | Preterm LabourSwitzerland
-
Thomas Jefferson UniversityCompleted
-
PreTeL, IncDuke University; University of RochesterRecruitingPreterm Birth | Threatened Preterm Labor | PreTerm LaborUnited States
Clinical Trials on Survey, Sample collection
-
Ohio State University Comprehensive Cancer CenterGuardant Health, Inc.CompletedColorectal CarcinomaUnited States
-
Indiana UniversityCompletedDepression | Stress | Inflammatory Bowel Diseases | Dietary Habits | Mental Health Wellness 1 | Happiness | Consciousness, Level Altered | EcstasyUnited States
-
University of California, San FranciscoTobacco Related Disease Research Program; Alere San DiegoRecruitingSmoking Cessation | Lung Carcinoma | Cigarette Smoking-Related CarcinomaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingMalignant Solid Neoplasm | COVID-19 Infection | Hematopoietic and Lymphatic System NeoplasmUnited States
-
New Mexico Cancer Research AllianceNational Cancer Institute (NCI)RecruitingMalignant NeoplasmUnited States
-
Masonic Cancer Center, University of MinnesotaCompletedAcute Leukemia | Chemotherapy-Induced Gut Barrier DamageUnited States
-
Institut PasteurRecruiting
-
Poitiers University HospitalRecruitingPsoriasis | Psoriatic ArthritisFrance
-
Ohio State University Comprehensive Cancer CenterNot yet recruitingTobacco-Related CarcinomaUnited States
-
Ohio State University Comprehensive Cancer CenterCompletedStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Advanced Lung Carcinoma | Metastatic Lung Carcinoma | Stage IV Lung Cancer AJCC v8United States